about
Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical rolesAntidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 yearsLegal highs: staying on top of the flood of novel psychoactive substancesPsychedelicsAyahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies.Psychedelic drug use in healthy individuals: A review of benefits, costs, and implications for drug policyClinical applications of hallucinogens: A review.Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI)Role of psilocybin in the treatment of depression.Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.LSD treatment in Scandinavia: emphasizing indications and short-term treatment outcomes of 151 patients in Denmark.Therapeutic Applications of Classic Hallucinogens.Back to the future: Research renewed on the clinical utility of psychedelic drugs.Olanzapine as the ideal "trip terminator"? Analysis of online reports relating to antipsychotics' use and misuse following occurrence of novel psychoactive substance-related psychotic symptoms.Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population.Does psychedelic drug use reduce risk of suicidality? Evidence from a longitudinal community-based cohort of marginalised women in a Canadian setting.The 21st century psychedelic renaissance: heroic steps forward on the back of an elephant.Increased nature relatedness and decreased authoritarian political views after psilocybin for treatment-resistant depression.The relationships of classic psychedelic use with criminal behavior in the United States adult population.The link between use of psychedelic drugs and mental health problems.Unifying Theories of Psychedelic Drug Effects.Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and DevelopmentMore Realistic Forecasting of Future Life Events After Psilocybin for Treatment-Resistant DepressionDrug policy, values and the public health approach –four lessons from drug policy reform movementsPredicting Responses to Psychedelics: A Prospective Study
P2860
Q22241778-14E8EC5E-3760-4F5F-A5C2-2BAC37484A04Q26746137-248EC68C-F1A4-4BDF-832A-C3F51E209358Q26799231-0B8630CC-F4C4-47B4-AAC0-5AB3CDF3ECDAQ30359998-D8B29E1B-B01E-4A14-A71B-9CC450FCC0CCQ33693380-D676F3FC-43A4-4623-848E-4B4CBFB5633BQ34178760-3241C433-9562-4EC6-B7EF-4F0D005658AFQ34535259-8EDC2943-EC4A-44CA-ABC7-BC7F1F1E67C1Q36999815-C4ADD427-AABB-4096-A81C-16A6739727BCQ37582715-0712ABF8-A817-47DC-8491-76FF86ADB649Q37722650-7D2DA08A-5848-4927-94B7-85653DBB8B9CQ38373370-27B8EFBF-B3C7-4AAE-8AE7-9575816211F8Q38781678-AFAEE1B3-6907-4162-B536-0FFD9F551E02Q38788397-DF0B038E-372E-4767-8FDC-E2796009DD5CQ40689652-9286DDDD-023D-4A8A-ADBD-78156DBC386FQ41586201-362EFDE4-3FA1-4592-B162-4E7DC1D27E43Q41932270-B934B389-D36C-4D4D-812B-01AF73FD5BD0Q47640031-249CE6B4-0A66-4772-AB2A-9E124CDADCB8Q47654338-EEF03C48-4787-4256-94E2-1CD57410A59AQ50078290-4A62D0F7-1F12-4A33-A34C-E4641C989BF4Q50564306-60DB290E-E198-43D4-B0CC-FC801342F03BQ52641641-31C306DD-8321-4DE8-A4B6-B626F123FE79Q57309250-F2D7734C-D1B8-4EFE-83C8-2AD897D0F847Q58122738-D989B745-5A84-4887-BDC6-DB8685D7DFF6Q58200530-C403A16D-3939-4605-9724-8877FC1A0548Q59137436-203E07B6-46E4-435F-9B4B-D3D321B9F447
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Psychedelics and mental health: a population study
@ast
Psychedelics and mental health: a population study
@en
Psychedelics and mental health: a population study
@en-gb
Psychedelics and mental health: a population study
@nl
type
label
Psychedelics and mental health: a population study
@ast
Psychedelics and mental health: a population study
@en
Psychedelics and mental health: a population study
@en-gb
Psychedelics and mental health: a population study
@nl
prefLabel
Psychedelics and mental health: a population study
@ast
Psychedelics and mental health: a population study
@en
Psychedelics and mental health: a population study
@en-gb
Psychedelics and mental health: a population study
@nl
P2860
P3181
P1433
P1476
Psychedelics and mental health: a population study
@en
P2093
Pål-Ørjan Johansen
Teri S Krebs
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0063972
P407
P577
2013-01-01T00:00:00Z